Weight-loss medications could alleviate migraine pain and reducing asthma symptoms, according to new research.

Experts have noted that individuals using these drugs reported a decrease in asthma flare-ups and a reduced reliance on inhalers.

Separately, a study has drawn a connection between the drug Wegovy and a decline in prescriptions for migraine medication among women taking it for weight management.

These findings, unveiled at the European Congress On Obesity in Turkey, contribute to a growing body of evidence suggesting that glucagon-like peptide-1 receptor agonist (GLP-1RA) drugs may offer advantages beyond their primary use for weight loss .

In England, these medications are already prescribed to mitigate the risk of heart attacks and strokes.…